the new HIV drug, Isentress (raltegravir)

November 2007

You'll hear about the new HIV drug, Isentress (raltegravir).

It's the first in a new class...integrase inhibitors.

HIV integrase is one of three enzymes needed by HIV to reproduce. Older drugs block the other two enzymes...reverse transcriptase and protease.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Myths prevent many people from getting flu vaccine
Infectious Diseases Methicillin-resistant Staph aureus (MRSA) infections are on the rise
Infectious Diseases the new HIV drug, Isentress (raltegravir)
Diabetes acute pancreatitis from Byetta
Diabetes Exubera (inhaled insulin) will be discontinued
Pediatrics The recent withdrawal of infant cough and cold OTCs has parents asking how to alleviate cold symptoms in young children
Pediatrics what to do if a child's antibiotic is accidentally left out of the refrigerator
Respiratory & Allergy some patients don't want to change from their albuterol CFC inhalers to the newer HFA versions
Respiratory & Allergy whether to use levalbuterol (Xopenex) instead of albuterol
Psychiatry new warnings about potentially fatal arrhythmias with haloperidol
Smoking Cessation bizarre psychiatric effects in patients using Chantix (varenicline) to stop smoking
Supplements Akavar 20/50 for weight loss
Gastroenterology which antibiotic regimens to use for treating H. pylori
Osteoporosis The latest Reclast study emphasizes the importance of treating patients for osteoporosis after a hip fracture
Medicare when some Medicare Part D patients fall into the dreaded "donut hole"